Atmo Biosciences
Demystifying the Human GutAtmo Biosciences
The Atmo Gas Capsule is a world first patented solution to accurately profile the gases within the gut, leading to better diagnosis and treatment of patients.
Blog Posts
30th June, 2025
Media Release: Atmo Biosciences announces publication of pivotal clinical study results supporting initial indication
Atmo Biosciences announces publication of pivotal clinical study results supporting initial indicati...
30th June, 2025
Media Release: Atmo Biosciences Strengthens IP Portfolio with Assignment of Patents from RMIT University
Atmo Biosciences Strengthens IP Portfolio with Assignment of All Patents from RMIT University. • Atm...
27th June, 2025
Press release: Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule
Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule • US FDA 510(k) regula...
26th June, 2025
Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule.
27 June 2025. Atmo Biosciences is delighted to announce that it has received US Food and Drug Admini...
14th April, 2025
Atmo Biosciences Strengthens IP Portfolio with Assignment of Patents from RMIT University
April 15, 2025. Atmo Biosciences today announced the successful assignment of its foundational paten...
4th March, 2025
Atmo Biosciences announces publication of pivotal clinical study results supporting initial indication.
March 4, 2025. Today, Atmo Biosciences announced the publication of pivotal clinical study data in C...
4th November, 2024
Atmo awarded Stage 2 funding through ANDHealth+ program.
14 October 2024. Atmo Biosciences is pleased to announce that it has been awarded funding through th...
15th October, 2024
Atmo awarded Stage 2 funding through ANDHealth+ program.
14 October 2024. Atmo Biosciences is pleased to announce that it has been awarded funding through th...
2nd May, 2024
Atmo Gas Capsule used in Florida State University study assessing gastrointestinal impact of a fasting diet
May 2, 2024. Clinical Research. Atmo Biosciences’ ingestible gas-sensing capsule was used to assess ...
9th April, 2024
Atmo Biosciences reaches primary endpoints in pivotal clinical study for initial indication
April 9, 2024. Atmo Biosciences is delighted to report that it has successfully reached its primary ...